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Abstract
Background: Abnormal aortic flow patterns in bicuspid aortic valve disease (BAV) may be partly responsible for the
associated aortic dilation. Aortic valve replacement (AVR) may normalize flow patterns and potentially slow the
concomitant aortic dilation. We therefore sought to examine differences in flow patterns post AVR.
Methods: Ninety participants underwent 4D flow cardiovascular magnetic resonance: 30 BAV patients with prior AVR
(11 mechanical, 10 bioprosthetic, 9 Ross procedure), 30 BAV patients with a native aortic valve and 30 healthy subjects.
Results: The majority of subjects with mechanical AVR or Ross showed normal flow pattern (73% and 67%
respectively) with near normal rotational flow values (7.2 ± 3.9 and 10.6 ± 10.5 mm2/ms respectively vs 3.8 ± 3.1 mm2/s
for healthy subjects; both p > 0.05); and reduced in-plane wall shear stress (0.19 ± 0.13 N/m2 for mechanical AVR vs. 0.
40 ± 0.28 N/m2 for native BAV, p < 0.05). In contrast, all subjects with a bioprosthetic AVR had abnormal flow patterns
(mainly marked right-handed helical flow), with comparable rotational flow values to native BAV (20.7 ± 8.8 mm2/ms
and 26.6 ± 16.6 mm2/ms respectively, p > 0.05), and a similar pattern for wall shear stress. Data before and after AVR
(n = 16) supported these findings: mechanical AVR showed a significant reduction in rotational flow
(30.4 ± 16.3→ 7.3 ± 4.1 mm2/ms; p < 0.05) and in-plane wall shear stress (0.47 ± 0.20→ 0.20 ± 0.13 N/m2; p < 0.05),
whereas these parameters remained similar in the bioprosthetic AVR group.
Conclusions: Abnormal flow patterns in BAV disease tend to normalize after mechanical AVR or Ross procedure, in
contrast to the remnant abnormal flow pattern after bioprosthetic AVR. This may in part explain different aortic growth
rates post AVR in BAV observed in the literature, but requires confirmation in a prospective study.
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Background
Bicuspid aortic valve disease (BAV) is the most common
congenital heart disease (1–2% of the population) and is
associated with ascending aortic dilation in up to 80% of
cases [1]. While traditionally the BAV aortopathy has
been described as an intrinsic aortopathy, recent
advances in cardiovascular magnetic resonance (CMR)
have suggested that the flow pattern in the ascending
aorta may be a major contributor to the aortopathy in
BAV [2–5]. 4D flow CMR allows visualization and quan-
tification of the blood flow in the aorta in a 3D image.
Using this technique we have recently shown that the in-
herent restricted leaflet opening of BAV, even when
functioning normally, causes an asymmetrical, off center
flow jet which hits the ascending aortic wall, leading to
marked rotational (helical) flow [4]. This abnormally
high rotational flow is associated with increased ascend-
ing aortic diameters. Part of the proposed mechanism
includes increased wall shear stress, which is a surrogate
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marker for the friction the blood flow exerts onto the
aortic wall [4]. The concept that increased wall shear
stress contributes to the BAV aortopathy is further sup-
ported by a recent study which showed that histopatho-
logical changes (such as reduced elastin) in excised
aortas from BAV patients only occurred in areas with
high wall shear stress but not in areas with normal or
low wall shear stress, as assessed with 4D flow CMR
prior to aortic resection [6].
Patients with a BAV suffer from valve disease at a
younger age than patients with trileaflet aortic valves
and the majority of BAV patients will require aortic
valve replacement (AVR) in their lifetime [7]. Given the
likely pathophysiological effects of the abnormal helical
flow on aortic dilation in BAV disease, examining the
flow patterns in the proximal aorta after AVR may pro-
vide novel insights. A recent pilot study examined these
in mainly trileaflet aortic valve disease [8], and suggested
that different AVR types may result in different flow pat-
terns. To date however, no study has assessed the impact
of AVR alone on the flow abnormalities in specifically
BAV. We therefore hypothesized that AVR may favorably
alter flow patterns in the ascending aorta in patients with
a BAV. We also sought to examine in this pilot study the
flow patterns after different AVR types (bioprosthetic
versus mechanical) to determine if these differ.
Methods
Patient recruitment
We prospectively enrolled 105 participants recruited
from cardiology clinics and CMR lists between January
2011 and July 2015 in a cross-sectional cohort study.
This included 45 BAV patients either awaiting or having
previously undergone AVR surgery. We excluded any
BAV patients with other complex heart disease such as
atrioventricular septal defect, hypoplastic left heart
syndrome and aortic coarctation. From the 45 patients,
we excluded 7 patients from the main analysis who
underwent concomitant aortic root replacement, 5 pa-
tients who underwent aortic valve repair and 3 patients
who had CMR contraindications after AVR. Prosthetic
valve types in the remaining 30 patients were mechanical
bileaflet (n = 11), bioprosthetic (n = 10) or a Ross proced-
ure (n = 9). The 11 patients with mechanical AVR (AVR-
mechanical) had bileaflet tilting disc type in all cases,
either an ATS Medical Manufacturing Company
(Minneapolis, Minnesota, USA) valve (23-25 mm), n = 5;
or an ON-X ACE (CryoLife, Incorporated, Kennesaw,
Georgia, USA) aortic valve (21-27 mm), n = 6. Valve
models in the bioprosthetic aortic valve replacement
group (AVR-tissue) were Perimount Magna Ease
(Edwards Lifesciences Corporation, Irvine, California,
USA) (23-27 mm), n = 4; Trifecta (Abbot, St. Jude
Medical, Abbott Park, Illinois, USA) (23-27 mm), n = 4;
Hancock II porcine (Medtronic, Minneapolis, Minnesota,
USA) (27 mm), n = 1 and Mitroflow (LivaNova, London,
England) pericardial (21 mm), n = 1. The Ross group had
a longer time interval between operation (often in child-
hood) and imaging. We compared the valve replacement
groups with 30 age- and sex-matched healthy subject co-
hort and 30 un-operated bicuspid aortic valve patients
matched to the post-operative peak velocity values of the
AVR group. All of these control patients participated in
our initial cohort study [4]. A sub-group of 16 BAV pa-
tients also had CMR assessment both pre- and post-
operatively, allowing comparison of flow patterns before
and after AVR. Thirteen of these patients participated in
our initial cohort study [4] prior to their valve replace-
ment. The study complies with the declaration of Helsinki
and was approved by the West Berkshire ethics commit-
tee. All participants gave written informed consent.
Cardiovascular magnetic resonance acquisition
Each subject underwent a CMR scan on a 3 Tesla sys-
tem (Trio, Siemens Healthineers, Erlangen, Germany)
for anatomical and 4D flow assessment using a 32-
channel cardiac surface coil. All images were electrocar-
diogram (ECG)-gated. Balanced steady-state free-
precession (bSSFP) cine sequences acquired during a
single breath-hold were used for aortic dimension mea-
surements at the level of the pulmonary arteries and for
left ventricular (LV) volume assessment [9]. The velocity
across the aortic valve was measured using through-
plane phase contrast velocity mapping in an image slice
placed perpendicular to the ascending aorta, just above
the valve tips (at the vena contracta). Commercial
CMR42 software (Circle Cardiovascular Imaging Inc.,
Calgary, Canada) was used for analysis of standard ana-
tomical and velocity parameters. Aortic diameters were
measured from inner edge to inner edge at end-diastole.
4D flow assessment
Flow-sensitive gradient-echo pulse sequence CMR was
used to characterize and quantify 4D flow hemodynamics
in the thoracic aorta. Datasets were acquired with
prospective ECG-gating during free-breathing, using a re-
spiratory navigator. The image acquisition volume was in
an oblique sagittal plane encompassing the whole thoracic
aorta. Sequence parameters: echo time 2.5 ms, repetition
time 5.1 ms, flip angle 7° (15° if Multihance (gadobenate
dimeglumine, Bracco Milan, Italy) contrast agent was used
to improve image quality in patients with a peak velocity >
3 m/s), voxel size 1.9–2.0 × 1.5–1.7 × 2.0–2.2 mm3, tem-
poral resolution 40 ms. The velocity encoding range was
determined using the lowest non-aliasing velocity on
scout measurements (healthy subject cohort 1–1.5 m/s;
BAV patients 1.5–4.5 m/s). Dataset processing, calculation
of flow angle, flow displacement, rotational flow and wall
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shear stress calculation were conducted with custom soft-
ware in Matlab version R2010a and R2015a (The Math-
Works Inc., Natick, Massachusetts, USA) and EnSight
Version 10.02(d) (CEI Inc., Apex, North Carolina, USA)
as described previously [10–13]. All measures were aver-
aged over peak systole (one time frame before and three
after peak systolic flow) to mitigate measurement noise.
Helical flow (Fig. 1 and Table 1) was quantified using
the rotational component of flow (which is the integral
of vorticity with respect to the cross-sectional area of
the aorta), and categorized as defined previously [4],
with normal-helical flow between − 5 and 11 mm2/s, ab-
normal right-handed rotational flow > 11 mm2/s, and
abnormal left-handed rotational flow < − 5 mm2/s. To
enable comparable statistical analysis, absolute rotational
flow values were used to assess the amount of rotational
(helical) flow irrespective of the orientation of the rota-
tion. Complex flow was defined as a lack of an observ-
able coherent rotational (helical) flow pattern.
The flow angle (Fig. 1 and Table 1) represents the angle
between the line perpendicular to the short axis analysis
plane of the aorta and the instantaneous mean flow vector
at peak systole [14]. Flow displacement (Fig. 1 and Table 1)
was calculated as the distance from the vessel center line
centroid to the velocity-weighted centroid (the center of
the flow jet) as described by Sigovan et al. [10] and normal-
ized to aortic diameters. Both flow angle and displacement
calculation assume that the “normal” flow is along the mid-
line which is not the case after mechanical valve replace-
ment as a mechanical valve usually leads to two off center
jets. Therefore flow angle and flow displacement may be
less meaningful parameters in this group.
Wall shear stress (Table 1) was calculated using the 3-
dimensional flow vector and magnitude data and mea-
sured in eight anatomical positions around the aortic
wall as well as the circumferentially averaged systolic
wall shear stress (WSScircavg). This combined the vector
magnitude of both through-plane and in-plane (rota-
tional) wall shear stress, as described previously [3, 4].
Statistical analysis
SPSS Statistics Version 24 (International Business
Machines Corporation, Armonk, New York, USA) was
used for statistical analysis. Data were tested for normal
distribution with the Kolmogorov-Smirnov test. Nor-
mally distributed data were analyzed using one-way
ANOVA with post-hoc Games-Howell analysis for
multiple group comparison. The paired student t-test
was used for comparison of individuals’ data before and
after valve replacement, while unpaired (independent)
t-test was used for between-group comparisons. A p-
value < 0.05 was considered significant. Independent
t-test was used for group comparison.
Results
General demographics and valve characterization
General demographics of the different BAV groups and
controls are summarized in Tables 2 and 3. As expected,
the AVR-tissue group were older (mean of 58 years) and
the Ross procedure (Ross) group were younger (mean of
24 years) compared to the AVR-mechanical group (mean
of 42 years). The native BAV group, the AVR-mechanical
and AVR-tissue all had significantly larger ascending
aortic diameters compared to healthy volunteers,
whereas only the Ross group’s ascending aortic
Fig. 1 Depiction of flow angle, flow displacement and rotational flow
Table 1 4D Flow parameter
Flow angle The angle of deviation from the center of
the aortic lumen
Flow displacement The distance of flow jet deviation from the
center of the aortic lumen indexed to
ascending aortic diameter
Rotational flow The blood flow circling within the aortic plane
WSScircavg Circumferentially averaged systolic wall
shear stress - surrogate marker for the
friction the blood flow exerts onto the
aortic wall
In-plane wall shear stress (the ‘rotational’ component) exerted by the
blood circling within the plane along the
aortic wall
Through-plane wall
shear stress
Exerted by the blood flowing through the
vessel.
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diameters were similar to the healthy subject group.
By exclusion criterion, no patient had an additional
(repaired) coarctation of the aorta or a hypoplastic
arch. Peak velocity was similar in all patient groups
and only the Ross group showed significant regurgita-
tion post AVR (mean regurgitant fraction 22.8%).
Mild patient-prosthesis mismatch occurred in only
one patient, who was in the AVR-mechanical group
(effective orifice area 0.8 cm2/m2).
Flow patterns after aortic valve replacement
The distribution of flow patterns is shown in Fig. 2. The
majority of BAV patients with a mechanical AVR (73%)
and those who had a previous Ross procedure (67%)
showed normal aortic flow patterns compared to bench-
mark patients with a native BAV, in whom only a minor-
ity had normal flow patterns (17%). In contrast, the
AVR-tissue group demonstrated abnormal helical flow
patterns in all patients (Fig. 3).
Table 2 Ascending aortic flow pattern parameters by aortic valve replacement subgroup
Healthy Subjects BAV- native AVR-mechanical AVR-tissue Ross
Total number (male) 30 (23) 30 (23) 11 (10) 10 (9) 9 (8)
Time after operation in months (range) 6 (3–14) 9 (1–37) 126 (1–268)
Indication for AVR:
Aortic stenosis 4 7 8
Aortic regurgitation 5 1 1
Both 2 2
Fusion pattern pre-AVR:
RL-BAV 7 5 Data
RN-BAV 2 5 unavailable
Others 2
Flow pattern post-AVR:
Normal flow 30 5 (17%) 8 (73%) 0 6 (67%)
Right-handed flow 21 (70%) 2 (18%) 8 (80%) 2 (22%)
Left-handed flow 1 (3%) 1 (9%) 1 (10%) 1 (11%)
Complex flow 3 (10%) 0 1 (10%)
Values are mean ± standard deviation except where indicated; BAV = bicuspid aortic valve; AVR = aortic valve replacement; RL-BAV = right-left coronary cusp fusion
pattern bicuspid aortic valve, RN-BAV = right-non-coronary cusp fusion pattern bicuspid aortic valve
Table 3 Ascending aortic flow pattern parameters by aortic valve replacement subgroup
Healthy
Subjects
n = 30
BAV- native
n = 30
AVR-mechanical
n = 11
AVR-tissue
n = 10
Ross
n = 9
ANOVA
Age in years 43 ± 17 42 ± 16 42 ± 12 58 ± 11 24 ± 12 p < 0.001
Systolic flow angle (°) 7.5 ± 5.3 25.6 ± 13.3* 16.5 ± 9.6 16.2 ± 8.5 9.8 ± 4.9† p < 0.001
Normalised flow displacement 0.038 ± 0.036 0.133 ± 0.072* 0.083 ± 0.076 0.163 ± 0.064* 0.096 ± 0.067 p < 0.001
Absolute rotational flow (mm2/ms) 3.8 ± 3.1 26.6 ± 16.6* 7.2 ± 3.9† 20.7 ± 8.8* 10.6 ± 10.5† p < 0.001
Mean systolic WSScircavg (N/m
2) 0.58 ± 0.15 0.77 ± 0.23* 0.67 ± 0.20 0.68 ± 0.20 0.80 ± 0.35 p = 0.012
Absolute systolic in-plane (rotational) WSS (N/m2) 0.07 ± 0.06 0.40 ± 0.28* 0.19 ± 0.13† 0.38 ± 0.19* 0.21 ± 0.17 p < 0.001
Max systolic through-plane WSS (N/m2) 0.76 ± 0.21 0.95 ± 0.44 0.91 ± 0.38 0.78 ± 0.215 1.03 ± 0.65 p = 0.206
RA-LP systolic WSScircavg (N/m
2) −0.12 ± 0.13 0.22 ± 0.31* 0.27 ± 0.22* 0.36 ± 0.26* 0.24 ± 0.67 p < 0.001
Peak velocity (m/s) – 2.3 ± 0.8 2.1 ± 0.5 2.1 ± 0.3 1.9 ± 0.8 p = 0.387
Ascending aortic diameter (mm) 28.6 ± 4.3 35.0 ± 6.7* 35.9 ± 4.4* 37.9 ± 5.2* 30.4 ± 8.3 p < 0.001
Diameter at sino-tubuar junction (mm) 27.9 ± 3.6 32.4 ± 6.4* 31.7 ± 7.8 32.9 ± 3.3 31.0 ± 6.0 p = 0.003
Diameter at sinuses (mm) 30.8 ± 3.5 32.9 ± 5.8 34.1 ± 6.7
(pre-AVR)
32.1 ± 2.3
(pre-AVR)
35.9 ± 5.7 p = 0.068
Aortic regurgitant fraction (%) – 8.8 ± 9.9 3.7 ± 2.8 5.8 ± 7.5 22.8 ± 20.6† p = 0.002
Left ventricular ejection fraction (%) – 68 ± 6 67 ± 15 70 ± 8 65 ± 10 p = 0.687
Values are mean ± standard deviation except where indicated; * = p < 0.05 compared to healthy volunteers; † = p < 0.05 compared to native BAV; BAV = bicuspid
aortic valve; AVR = aortic valve replacement; WSS = wall shear stress; WSScircavg = circumferentially averaged wall shear stress; RA-LP = right anterior – left posterior
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In keeping with these results, quantitative measures of
rotational flow were significantly increased in the BAV-
native and AVR-tissue groups (mean values 26.6 and
20.7 mm2/s respectively) compared to healthy subjects
(3.8 mm2/s, Fig. 4). In contrast, in the AVR-mechanical
and Ross group the degree of rotational flow was signifi-
cantly lower and close to normal.
Flow angle and flow displacement after aortic valve
replacement
The flow angle (the angle of deviation from the center of
the aortic lumen; Fig. 1) was significantly increased in
the native BAV group (25.6°) vs healthy controls (7.5°), p
< 0.05; Table 3. The AVR-mechanical and AVR-tissue
groups both had similar, moderately increased, values
(means 16.5° and 16.2° respectively) although these were
not significantly different from the healthy controls. The
Ross group had normal flow angle values (mean 9.8°).
Flow displacement is the ratio of the distance the flow
jet deviates from the center of the aortic lumen, indexed
to ascending aortic diameter at the level of the pulmon-
ary artery (Fig. 1). This was also significantly increased
in the native BAV and AVR-tissue group (0.133 and
0.163 respectively) compared to the healthy subject
group (0.038), p < 0.05 (Table 3). The AVR-mechanical
and Ross showed a trend towards higher values com-
pared to the healthy cohort group.
Wall shear stress after aortic valve replacement
Wall shear stress is a surrogate marker for the friction
the blood flow exerts onto the aortic wall. The overall
wall shear stress, described as the circumferentially aver-
aged systolic wall shear stress (WSScircavg), was slightly
higher than controls in all three AVR groups (Table 3)
but did not reach statistical significance. As expected, it
was increased in the BAV-native group compared to
Fig. 2 Ascending aortic flow patterns after three types of aortic valve replacement (AVR), compared to un-operated bicuspid aortic valve disease
(BAV) and healthy subjects
Fig. 3 Typical ascending aortic flow patterns after aortic valve replacement (AVR); a – healthy subject with a laminar flow pattern; b – native
bicuspid aortic valve disease with a right-handed helical flow pattern; c – AVR-mechanical with 2 laminar jets; d – AVR-tissue with a right-handed
helical flow pattern; e – AVR-Ross with a laminar flow pattern
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healthy subjects (p < 0.05). However, wall shear stress
consists of two components: The in-plane wall shear
stress (the ‘rotational’ component) exerted by the blood
circling within the plane along the aortic wall, and the
through-plane wall shear stress exerted by the blood
flowing through the vessel. When examining these com-
ponents separately, in-plane wall shear stress was signifi-
cantly higher in the AVR-tissue and BAV-native groups
(0.40 and 0.38 N/m2) compared to healthy volunteers
(0.07 N/m2, p < 0.05), in keeping with the higher degree
of rotational flow in these groups, but numbers were
small in the AVR-tissue group. In-plane systolic wall
shear stress was significantly lower in the AVR-
mechanical group (0.19 N/m2, p < 0.05), with similar
values in the Ross group. Through-plane wall shear
stress (exerted by blood flowing along the long axis of
the aorta) was similar across all groups.
The BAV-native and all three AVR groups had the
highest wall shear stress values in the right anterior pos-
ition which corresponds to the outer curvature (Fig. 5).
In healthy subjects the wall shear stress was highest in
the posterior position, which corresponds to the inner
curvature.
Individual changes in aortic flow after aortic valve
replacement
Sixteen out of the 30 patients attended a study visit both
before and after AVR (10 with mechanical AVR, 6 with a
bioprosthetic AVR, Table 4). The AVR-mechanical group
all had abnormal flow patterns at baseline (7/10 with
right-handed helical flow; 3/10 with complex flow), but
after AVR all flow patterns either normalized (7/10) or
showed marked reduction in the rotational (helical)
component of flow (3/10). As a result the group showed
a significant reduction in almost all haemodynamic pa-
rameters including mean rotational flow (30.4 ± 16.3 →
7.3 ± 4.1 mm2/ms; p < 0.05, Fig. 6), WSScircavg (1.02 ±
0.21 → 0.68 ± 0.21 N/m2; p < 0.05), as well as both the
individual components, in-plane (0.47 ± 0.20 → 0.20 ±
0.13 N/m2; p < 0.05) and through-plane wall shear stress
(1.43 ± 0.54→ 0.92 ± 0.39 N/m2; p < 0.05). The reduction
in systolic flow angle and normalized flow displacement
did not reach statistical significance (Table 4).
In the AVR-tissue group all patients also had abnormal
flow patterns at baseline (4/6 with right-handed helical
flow; 2/6 with complex flow). However, all 6 patients
had a residual right-handed flow pattern after AVR with
similar haemodynamic abnormalities, no statistically sig-
nificant change in mean rotational flow, normalized flow
displacement, systolic flow angle or in-plane wall shear
stress. There was a similar reduction in WSScircavg (1.04 ±
0.20 → 0.70 ± 0.21 N/m2; p < 0.05), through-plane wall
shear stress (1.47 ± 0.34 → 0.75 ± 0.21 N/m2; p < 0.05),
compared to the AVR-mechanical group. The small size
of this group limits the conclusions that can be drawn
however.
Discussion
Type of ascending aortic valve replacement
Recent advances in CMR imaging have suggested that
the flow pattern in the ascending aorta is a major con-
tributor to the aortopathy in BAV [2–5]. The marked
helical flow pattern with an increased wall shear stress is
thought to play an important role in the pathophysi-
ology. However, very little is known about how flow
patterns and wall shear stress are influenced by AVR.
Our small study suggests that both the AVR-mechanical
and Ross group appeared to have near normalization of
flow haemodynamics following AVR, while abnormal
helical flows appeared higher in the AVR-tissue group.
The findings were similar in the cross-sectional assess-
ments and in those imaged before and after AVR. The
numbers in some groups (particularly the AVR-tissue
group) were small however and this limits the strength
of conclusion. If true, one explanation for this
phenomenon may be that a bioprosthetic AVR is inher-
ently associated with increased rotational flow. Abnor-
mal helical flows post-AVR have also been shown in
Fig. 4 Mean rotational flow – comparison of the different aortic
valve replacement groups; * = p < 0.05 compared to native un-
operated bicuspid aortic valve disease
Fig. 5 Systolic wall shear stress (WSS): The anatomical positions are
shown at the bottom of the Fig. A = anterior (outer curvature);
LA = left anterior, L = left, LP = left posterior, P = posterior, RP = right
posterior, R = right, RA = right anterior; the height of the dots
indicates the wall shear stress value
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other studies following bioprosthetic AVR for trileaflet
aortic valve disease [8, 15–17], supporting the limited
data in our study. The pathophysiology for this would be
unknown however. We note that all patients with a bio-
prosthetic AVR imaged pre- and post-surgery had a
right-handed helical flow pattern after AVR, even though
2/6 of these patients had had a complex flow pattern
pre-operatively, which may suggest that the biopros-
thetic valve introduced a right-handed helical flow
pattern in those with complex flow preoperatively. An
alternative explanation may lie with the age at which the
operation occurs. Bioprosthetic AVR is more prevalent
in older patients, as was the case in our AVR-tissue
group, and bicuspid aortopathy increases with age. At
the later age of the bioprosthetic AVR, patients may
already exhibit larger aortas with the ‘typical’ anteriorly
bulging shape (Fig. 7) [18], and a trileaflet bioprosthetic
AVR may not be enough to normalize the flow pattern
in this setting. In contrast, the Ross procedure is
normally undertaken in childhood before much of the
aortopathy has developed, and it is conceivable that
replacing the diseased bicuspid aortic valve with a (tri-
leaflet) homograft may normalize the flow at this earlier
stage, as observed in our study. A mechanical AVR, on
the other hand, introduces a non- physiological flow pat-
tern consisting of two parallel flow jets arising off-center,
which our data suggests may reduce the overall
rotational flow, even in the presence of a dilated aorta.
Confirmation of this would however be required in
larger studies.
Wall shear stress after aortic valve replacement
While the AVR-mechanical group showed a reduction in
all wall shear stress components, the AVR-tissue group
only showed a statistically significant reduction in
through-plane and overall wall shear stress but not in-
plane wall shear stress. The reduction in through-plane
Table 4 Comparison ascending aortic flow pattern parameters before and after valve replacement
AVR-mechanical AVR-tissue
Pre-AVR Post-AVR p-value Pre-AVR Post-AVR p-value
Number 10 10 6 6
Absolute rotational flow (mm2/ms) 30.4 ± 16.3 7.3 ± 4.1 p = 0.001 35.6 ± 23.1 22.2 ± 6.0 p = 0.18
Systolic WSScircavg (N/m
2) 1.02 ± 0.21 0.68 ± 0.21 p = 0.001 1.04 ± 0.20 0.70 ± 0.21 p = 0.048
Absolute systolic in-plane WSS (N/m2) 0.47 ± 0.20 0.20 ± 0.13 p = 0.001 0.56 ± 0.32 0.44 ± 0.19 p = 0.41
Max systolic through-plane WSS (N/m2) 1.43 ± 0.54 0.92 ± 0.39 p = 0.04 1.47 ± 0.34 0.75 ± 0.21 p = 0.01
RA-LP systolic WSScircavg (N/m
2) 0.55 ± 0.66 0.28 ± 0.23 p = 0.19 0.77 ± 0.29 0.25 ± 0.27 p = 0.03
Systolic flow angle (°) 26.5 ± 9.3 17.1 ± 9.8 p = 0.77 23.8 ± 9.4 20.2 ± 7.2 p = 0.41
Normalised flow displacement 0.126 ± 0.093 0.069 ± 0.065 p = 0.18 0.166 ± 0.053 0.141 ± 0.068 p = 0.54
Peak velocity (m/s) 3.4 ± 1.5 2.0 ± 0.5 p = 0.02 3.7 ± 0.8 2.1 ± 0.4 p = 0.001
Regurgitant fraction (%) 38 ± 19 3 ± 2 p < 0.001 12 ± 14 2 ± 2 p = 0.21
Left ventricular ejection fraction (%) 71 ± 9 68 ± 16 p = 0.68 75 ± 9 75 ± 5 p = 0.91
Values are mean ± standard deviation except where indicated; BAV = bicuspid aortic valve; AVR = aortic valve replacement; WSS = wall shear stress;
WSScircavg = circumferentially averaged wall shear stress; RA-LP = right anterior – left posterior
Fig. 6 Mean rotational flow – comparison before and after aortic
valve replacement (AVR)
Fig. 7 a – Patient after bioprosthetic AVR with ascending aortic
aortopathy showing the ‘typical’ anteriorly bulging shape; b – Patient
after Ross procedure showing a normal shaped ascending aorta
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wall shear stress in both groups is most likely due to the
reduction in peak velocities after AVR. The in-plane (ro-
tational) component remained higher in the AVR-tissue
group, possibly due to the marked helical flow still seen
in these patients. Previous studies have suggested that
in-plane wall shear stress is a larger contributor to the
aortic dilation in BAV than through-plane wall shear
stress [4, 5]. In-plane wall shear stress is negligible in
healthy subjects, but significantly increased in BAV pa-
tients, even in young patients with normal ascending
aortic diameters, normal valve function and resulting
normal through-plane wall shear stress, suggesting that
the increased in-plane wall shear stress precedes aortic
dilation and may be a contributor towards the BAV
aortopathy [5].
Implications of flow on ascending aortic growth
A recent large retrospective study looked at 360 BAV
patients after the Ross procedure and showed no differ-
ence in aortic growth compared to the general popula-
tion [19]. The normalization of ascending aortic flow
seen in our Ross subgroup may be an explanation for
these findings. However, studies of aortic growth after
mechanical and bioprosthetic AVR in the literature are
inconclusive. All are retrospective, mostly echocardio-
graphic, studies and included either mainly or only
mechanical AVR [20–26]. The development of aortic an-
eurysms (defined as ascending aortic diameter > 4.5 cm)
was 10–22% [20, 24], though the need for ascending
aorta replacement after 15 years of follow-up remained
low at 1–3% [21, 22, 24]. Unsurprisingly, continued aor-
tic dilation was more likely in patients with enlarged
aortas at the time of surgery [24]. To date there are few
longitudinal studies examining the effect of AVR on aor-
tic growth rate and mechanical and bioprosthetic AVR
are not separately reported within these studies. While
some showed an increased growth rate after AVR (echo-
cardiography [25, 27, 28]; computed tomography (CT)
[29]), others showed an overall reduction in aortic
growth rate after AVR (echocardiography [23]; echocar-
diography or CT [30]; CT or CMR [26]). One explan-
ation for these discrepant findings may be that flow
profiles differ post mechanical and post bioprosthetic
AVR as suggested by the findings in our hypothesis-
generating study. Unfortunately no large study has
compared ascending aortic growth rate in mechanical vs
bioprostheic AVR in BAV, which would be ideal.
Using 4D flow CMR imaging biomarkers as predictors
for aortic growth has been examined in one small longi-
tudinal cohort study. In 13 unoperated BAV patients,
normalized flow displacement but not wall shear stress
correlated with aortic growth [31]. In our cohort, only
the AVR-tissue group had significantly increased nor-
malized flow displacement values compared to healthy
subjects. The impact of rotational flow has not previ-
ously been assessed.
Limitations
Patient numbers in this study were relatively small and
not all patients, particularly the Ross group, had data
available both before and after AVR. In the mechanical
and bioprosthetic groups, different models of aortic
valve prosthesis were used and it is feasible that there
are differing flow patterns associated with different valve
models. However, both mechanical valve models were
of a similar design (bileaflet tilting disc type). In
addition, almost all bioprosthetic valves have a similar
shaped valve, which is designed to be as close as pos-
sible to the native trileaflet valve. All mechanical
AVRs were implanted in a R-L orientation in relation
to the ascending aorta.
The interval between valve replacement and CMR as-
sessment was up to 3 years in the AVR groups and be-
tween 1 month and 22 years in the Ross group, and up
to 3 years in other AVR groups. The ages of each AVR
group were also significantly different - very young pa-
tients tend to undergo a Ross operation, whereas older
patients more often opt for a bioprosthetic AVR rather
than a mechanical AVR, and age may influence flow pat-
terns through differences in aortic shape and stiffness,
which could be an important confounder.
4D flow CMR is a new imaging technique but
measures such as wall shear stress have been validated,
even though the true wall shear stress is likely to be
higher than the measured value, due to limited spatial
resolution, as discussed previously [32]. This cross-
sectional study is unable to assess the impact of flow
normalization on aortic growth rate, for which further
longitudinal follow-up will be necessary.
Conclusion
Abnormal helical flow in BAV disease is significantly re-
duced after mechanical AVR or Ross procedures. Follow-
ing bioprosthetic AVR, however, our small group
suggested that abnormal helical flow patterns remain
similar to un-operated and pre-operative values, but
conclusions are limited by the small group size. These
findings suggest for the first time that the AVR type may
be an influence on aortic flow patterns, but requires
confirmation. Whether improved haemodynamics have
clinical implications such as a reduction in aortic growth
also remains unknown. As ascending aortic growth in
BAV is slow, prospective studies would require a long
follow-up period. A reasonable alternative to further in-
vestigate the potential differences in valve prostheses
suggested by our study in a more timely manner, would
be larger retrospective studies to compare aortic growth
following mechanical and bioprosthetic AVR.
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